Clinical trial
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
NCT03179800 · Vascular Dynamics, Inc., Industry · Active, not recruiting
Key facts
| NCT number | NCT03179800 |
|---|---|
| Title | CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™ |
| Official title | CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™ |
| Acronym | CALM-2 |
| Lead sponsor | Vascular Dynamics, Inc., Industry |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Hypertension, Resistant Hypertension |
| Intervention type | Device, Other |
| Interventions | MobiusHD, Sham Implantation |
| Enrollment | 300 |
| Start date | Oct 19, 2017 |
| Primary completion | May 1, 2025 |
| Completion | May 1, 2025 |
| First posted | Jun 7, 2017 |
| Last update posted | Jul 18, 2024 |
| Countries | France, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: